Product Images Divalproex Sodium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Divalproex Sodium NDC 70518-3364 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
MM2 - Divalproex Sodium 500mg 70518 3364 01
This is the label of a pill bottle containing Divalproex Sodium 500 mg Delayed-Release tablets. It includes important information such as the quantity, RX date, expiration date, lot number, and the source National Drug Code (NDC). The directions for use are not available, but there is a reminder to keep the medication out of reach of children. The bottle was repackaged by a company known as RemedyRepack Inc., located in Indiana, PA.*
Remedy_Label - Remedy Label
Divalproex Sodium is a delayed-release tablet with a strength of 500mg. The package contains 100 tablets with LOT # and NDC # for reference. It is RX only medication and should be kept away from the reach of children. The direction for use is provided in the package insert. It is recommended to store at a temperature of 20-26°C (63-77°F) with excursions allowed up to 15-30°C (59-86°F) as per USP guidelines. The medication has been repackaged by RemedyRepack Inc. located in Indiana, PA.*
Chemical Structure - divalproex 01
Figure 1 - divalproex 02
The text appears to be a table or a graph showing percentages and some abbreviations. The abbreviations could indicate different studies and the percentages may refer to scores or results. Without further context or information, it is difficult to provide a more specific description.*
Figure 2 - divalproex 03
This appears to be a chart created to show the reduction in CPS (cycles per second) rate for patients using Divalproex sodium compared to a placebo treatment. The chart shows percentages ranging from -50% to 100% for various improvements and worsening of the condition. The chart also shows that 50% of patients experienced an improvement in their condition while using Divalproex sodium.*
Figure 3 - divalproex 04
This text presents a chart or graph that indicates the percentage of patients who experienced either an improvement or worsening in CPS (presumably a medical condition) rate when exposed to a high or low dose. However, there is insufficient information to determine what CPS entails or the context in which the data is presented.*
Figure 4 - divalproex 05
Placebo and Divalproex Sodium are mentioned in two different studies.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.